As of 2026-04-04, the EV/EBITDA ratio of Gohealth Inc (GOCO) is 3.51. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Gohealth's latest enterprise value is 569.30 mil USD. Gohealth's TTM EBITDA according to its financial statements is 162.26 mil USD. Dividing these 2 quantities gives us the above Gohealth EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 5.0x - 9.7x | 7.3x |
| Forward P/E multiples | 7.9x - 13.1x | 11.2x |
| Fair Price | (4.84) - 66.44 | 24.74 |
| Upside | -479.6% - 5111.1% | 1840.7% |
| Date | EV/EBITDA |
| 2026-04-02 | 3.51 |
| 2026-04-01 | 3.51 |
| 2026-03-31 | 3.53 |
| 2026-03-30 | 3.53 |
| 2026-03-27 | 3.53 |
| 2026-03-26 | 3.54 |
| 2026-03-25 | 3.56 |
| 2026-03-24 | 3.57 |
| 2026-03-23 | 3.55 |
| 2026-03-20 | 3.53 |
| 2026-03-19 | 3.53 |
| 2026-03-18 | 3.53 |
| 2026-03-17 | 3.54 |
| 2026-03-16 | 3.54 |
| 2026-03-13 | 3.54 |
| 2026-03-12 | 3.54 |
| 2026-03-11 | 3.56 |
| 2026-03-10 | 3.58 |
| 2026-03-09 | 3.56 |
| 2026-03-06 | 3.55 |
| 2026-03-05 | 3.55 |
| 2026-03-04 | 3.55 |
| 2026-03-03 | 3.53 |
| 2026-03-02 | 3.52 |
| 2026-02-27 | 3.52 |
| 2026-02-26 | 3.52 |
| 2026-02-25 | 3.53 |
| 2026-02-24 | 3.53 |
| 2026-02-23 | 3.52 |
| 2026-02-20 | 3.54 |
| 2026-02-19 | 3.54 |
| 2026-02-18 | 3.54 |
| 2026-02-17 | 3.54 |
| 2026-02-13 | 3.56 |
| 2026-02-12 | 3.55 |
| 2026-02-11 | 3.55 |
| 2026-02-10 | 3.58 |
| 2026-02-09 | 3.57 |
| 2026-02-06 | 3.58 |
| 2026-02-05 | 3.57 |
| 2026-02-04 | 3.60 |
| 2026-02-03 | 3.59 |
| 2026-02-02 | 3.60 |
| 2026-01-30 | 3.59 |
| 2026-01-29 | 3.60 |
| 2026-01-28 | 3.59 |
| 2026-01-27 | 3.60 |
| 2026-01-26 | 3.60 |
| 2026-01-23 | 3.61 |
| 2026-01-22 | 3.62 |